{"id":5,"date":"2018-09-06T10:56:34","date_gmt":"2018-09-06T10:56:34","guid":{"rendered":"http:\/\/www.anzrag.com\/wordpress\/?page_id=5"},"modified":"2018-09-06T12:20:04","modified_gmt":"2018-09-06T12:20:04","slug":"information-for-participants","status":"publish","type":"page","link":"http:\/\/www.anzrag.com\/wordpress\/information-for-participants\/","title":{"rendered":"Information for Participants"},"content":{"rendered":"<p>Ophthalmologists are asked to refer participants that they feel fit the suitability criteria by posting, faxing or e-mailing a completed referral and consent form, or phoning our office. Following this, the participant will be contacted by the\u00a0<em><strong>Australian and New Zealand Registry of Advanced Glaucoma<\/strong><\/em>, and a DNA collection kit will be posted to them along with instructions.<\/p>\n<p>The participant will be asked to return the DNA (usually blood) sample to the registry using a pre-paid package. Analysis of the sample will occur once received, with DNA extraction and gene sequencing conducted in our laboratories at Flinders University under the guidance of Assoc\/Professor Jamie Craig. Some samples will be screened for specific genes (eg\u00a0<em>Myocilin<\/em>\u00a0and\u00a0<em>CYP1B1<\/em>). The results will then be analysed and the information gained disseminated to the referring ophthalmologist and the participant. Genetic counselling will also be offered.<\/p>\n<p>This service is offered at no cost to the participant. The patient\u2019s current glaucoma treatment regime will not be affected as they will continue to visit their regular ophthalmologist.<\/p>\n<p>It is envisaged that as well as offering a clinical service for participants by screening for known gene mutations (such as\u00a0<em>Myocilin<\/em>\u00a0and\u00a0<em>CYP1B1<\/em>), new genes may also be discovered as a result of collecting the DNA specimens.<\/p>\n<p>People who think they may suit the\u00a0<a href=\"http:\/\/www.anzrag.com\/wordpress\/registry-criterion\/\">selection criteria<\/a>\u00a0may\u00a0<a href=\"http:\/\/www.anzrag.com\/wordpress\/contact-us\/\">contact the office<\/a>\u00a0for further information on how to take part.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ophthalmologists are asked to refer participants that they feel fit the suitability criteria by posting, faxing or e-mailing a completed referral and consent form, or phoning our office. Following this, the participant will be contacted by the\u00a0Australian and New Zealand Registry of Advanced Glaucoma, and a DNA collection kit will be posted to them along [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/pages\/5"}],"collection":[{"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/comments?post=5"}],"version-history":[{"count":3,"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/pages\/5\/revisions"}],"predecessor-version":[{"id":38,"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/pages\/5\/revisions\/38"}],"wp:attachment":[{"href":"http:\/\/www.anzrag.com\/wordpress\/wp-json\/wp\/v2\/media?parent=5"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}